Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
285.83
-1.34 (-0.46%)
Aug 14, 2025, 2:22 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Life Science | 1.03B | Log In | Log In | Log In | Log In | Upgrade |
Life Science Growth | -1.86% | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics | 1.54B | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics Growth | 0.87% | Log In | Log In | Log In | Log In | Upgrade |
Other Segments | 500.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Segments Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Life Science Operating Profit | - | Log In | Log In | Log In | Log In | Upgrade |
Life Science Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics Operating Profit | - | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Segments Operating Profit | - | Log In | Log In | Log In | Log In | Upgrade |
Other Segments Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -83.33% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -83.33% | Log In | Log In | Log In | Log In | Upgrade |
Life Science Segment Profit | 582.40M | Log In | Log In | Log In | Log In | Upgrade |
Life Science Segment Profit Growth | 2.56% | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics Segment Profit | 796.60M | Log In | Log In | Log In | Log In | Upgrade |
Clinical Diagnostics Segment Profit Growth | -6.41% | Log In | Log In | Log In | Log In | Upgrade |
Other Segments Segment Profit | -100.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Segments Segment Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -83.33% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 1.04B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -0.12% | Log In | Log In | Log In | Log In | Upgrade |
EMEA | 834.10M | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | 4.18% | Log In | Log In | Log In | Log In | Upgrade |
APAC | 521.60M | Log In | Log In | Log In | Log In | Upgrade |
APAC Growth | -5.43% | Log In | Log In | Log In | Log In | Upgrade |
Other Regional | 169.30M | Log In | Log In | Log In | Log In | Upgrade |
Other Regional Growth | -6.91% | Log In | Log In | Log In | Log In | Upgrade |